Genetic dissimilarity of two fluconazole-resistant Candida albicans strains causing meningitis and oral candidiasis in the same AIDS patient

Journal of Clinical Microbiology

Volumn 34, Issue 6, 1996, Pages 1542-1545

  Berenguer, Juan ^a   Diaz Guerra, Teresa M ^b   Ruiz Diez, Beatriz ^b   Bernaldo De Quiros, Juan Carlos L ^a   Rodriguez Tudela, Juan L ^b   Martinez Suarez, Joaquin V ^b  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; FLUCONAZOLE; FLUCYTOSINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; CANDIDA ALBICANS; CASE REPORT; CEREBROSPINAL FLUID CULTURE; DNA FINGERPRINTING; DNA HYBRIDIZATION; FATALITY; FUNGAL MENINGITIS; HUMAN; KARYOTYPE; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION MAPPING; THRUSH;

CANDIDA; CANDIDA ALBICANS;

EID: 0029973166     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.34.6.1542-1545.1996     Document Type: Article

References (38)

1. Barnett, J. A., R. W. Payne, and D. Yarrow. 1990. Yeasts: characteristics and identification, 2nd ed. Cambridge University Press, Cambridge.
2. Berenguer, J., V. Fernàndez-Baca, R. Sánchez, and E. Bouza. 1995. In vitro activity of amphotericin B, flucytosine and fluconazole against yeasts causing bloodstream infections. Eur. J. Clin. Microbiol. Infect. Dis. 14: 362-365.
3. Bisbe, J., J. M. Miro, X. Latorre, A. Moreno, J. Mallolas, J. M. Gatell, J. Puig de la Bellacasa, and E. Soriano. 1992. Disseminated candidiasis in addicts who use brown heroin: report of 83 cases and review. Clin. Infect. Dis. 15:910-923.
4. Bläzquez, R., J. Berenguer, C. Sánchez-Carrillo, S. Moreno, T. Peláez, and E. Bouza. 1995. Utility of CHROMagar Candida, a new differential isolation medium in the mycological diagnosis of oropharyngeal candidiasis in HIV-infected patients, abstr. D7, p. 67. In Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
5. Bruinsma-Adams, I. K. 1991. AIDS presenting as Candida albicans meningitis: a case report. AIDS 5:1268-1269.
6. Diaz-Guerra, T. M., J. L. Rodríguez-Tudela, and J. V. Martínez-Suárez. 1995. Comparison of three molecular typing methods to evaluate strain variation among Candida albicans isolates from HIV positive patients with oral candidiasis, abstr. C57, p. 49. In Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
7. Ehni, W. F., and R. T. Ellison III. 1987. Spontaneous Candida albicans meningitis in a patient with the acquired immune deficiency syndrome. Am. J. Med. 83:806-807.
8. Eliopoulos, G. M., and R. C. Moellering, Jr. 1991. Antimicrobial combinations, p. 432-492. In V. Lorian (ed.), Antibiotics in laboratory medicine, 3rd ed. Williams & Wilkins, Baltimore.
9. Espinel-Ingroff, A., J. L. Rodríguez-Tudela, and I. V. Martínez-Suárez. 1995. Comparison of two alternative microdilution procedures with the National Committee for Clinical Laboratory Standards reference macrodilution method M27-P for in vitro testing of fluconazole-resistant and -susceptible isolates of Candida albicans. J. Clin. Microbiol. 33:3154-3158.
10. Francis, P., and T. J. Walsh. 1992. Evolving role of flucytosine in immunocompromised patients: new insights into safety, pharmacokinetics, and antifungal therapy. Clin. Infect. Dis. 15:1003-1018.
11. Kantor, H. L., H. A. Emsellen, J. E. Hogg, and G. L. Simon. 1984. Candida albicans meningitis in a parenteral drug abuser. South. Med. J. 77:404-405.
12. Laguna, F., J. L. Rodríguez-Tudela, and A. Enriquez. 1994. Fungemia due to fluconazole-resistant Candida albicans in a patient with AIDS. Clin. Infect. Dis. 19:542-543.
13. Lupetti, A., G. Guzzi, A. Paladini, K. Swart, M. Campa, and S.Senesi. 1995. Molecular typing of Candida albicans in oral candidiasis: karyotype epidemiology with human immunodeficiency virus-seropositive patients in comparison with that with healthy carriers. J. Clin. Microbiol. 33:1238-1242.
14. Lyman, C. A., and T. J. Walsh. 1992. Systemically administered antifungal agents. A review of their clinical pharmacology and therapeutic applications. Drugs 44:9-35.
15. Martínez-Suárez, J. V., J. Berenguer, R. Sánchez, and J. L. Rodríguez-Tudela. 1995. Comparison of a microdilution method with RPMI-2% glucose with the reference macrodilution test M27-P for in vitro testing of amphotericin B, flucytosine and fluconazole, abstr. D41, p. 73. In Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
16. Martínez-Suárez, J. V., and J. L. Rodríguez-Tudela. 1995. Patterns of in vitro activity of itraconazole and imidazole antifungal agents against Candida albicans with decreased susceptibility to fluconazole from Spain. Antimicrob. Agents Chemother. 39:1512-1516.
17. Meyer, W., T. G. Mitchell, E. Z. Freedman, and R. Vilgalys. 1993. Hybridization probes for conventional DNA fingerprinting used as single primers in the polymerase chain reaction to distinguish strains of Cryptococcus neoformans. J. Clin. Microbiol. 31:2274-2280.
18. Mover, D. V., and J. E. Edwards, Jr. 1993. Candida endophthalmitis and central nervous system infection, p. 331-355. In G. P. Bodey (ed.), Candidiasis: pathogenesis, diagnosis and treatment. Raven Press, New York.
19. National Committee for Clinical Laboratory Standards. 1992. Reference method for broth dilution antifungal susceptibility testing of yeasts. Proposed standard M27-P. National Committee for Clinical Laboratory Standards, Villanova, Pa.
20. Odds, F. C. 1988. Candida and candidosis, 2nd ed. Baillière Tindall, London.
21. Pfaller, M. A. 1995. Epidemiology of fungal infections: the promise of molecular typing. Clin. Infect. Dis. 20:1535-1539.
22. Polak, A. 1988. Combination therapy with antifungal drugs. Mycoses 31 (Suppl. 2):45-53.
23. Polanco, A. M., J. L. Rodríguez-Tndela, and J. V. Martínez-Suárez. 1995. Detection of pathogenic fungi in human blood by the polymerase chain reaction. Eur. J. Clin. Microbiol. Infect. Dis. 14:618-621.
24. Powderly, W. G., K. Robinson, and E. J. Keath. 1993. Molecular epidemiology of recurrent oral candidiasis in human immunodeficiency virus-positive patients: evidence for two patterns of recurrence. J. Infect. Dis. 168:463-466.
25. Rex, J. H., M. G. Rinaldi, and M. A. Pfaller. 1995. Resistance of Candida species to fluconazole. Antimicrob. Agents Chemotlicr. 39:1-8.
26. Rodríguez-Tiidela, J. L., and J. V. Martínez-Suárez. 1994 Improved medium for fluconazole susceptibility testing of Candida albicans. Antimicrob. Agents Chemother. 38:45-48.
27. Rodríguez-Tudela, J. L., and J. V. Martínez-Suárez. 1995. Defining conditions for microbroth antifungal susceptibility tests: influence of RPMI and RPMI-2% glucose on the selection of endpoint criteria. J. Antimicrob. Chemother. 35:739-749.
28. Rodríguez-Tudela, J. L., J. V. Martínez-Suárez, F. Dronda, F. Laguna, F. Chaves, and E. Valencia. 1995. Correlation of in-vitro susceptibility test results with clinical response: a study of azole therapy in AIDS patients. J. Antimicrob. Chemother. 35:793-804.
29. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
30. Sangeorzan, J. A, S. F. Bradley, X. He, L. T. Zarins, G. L. Ridenour, R. N. Tiballi, and C. A. Kauffman. 1994. Epidemiology of oral candidiasis in HIV-infected patients: colonization, infection, treatment, and emergence of fluconazole resistance. Am. J. Med. 97:339-346.
31. Scherer, S., and D. A. Stevens. 1988. A Candida albicans dispersed, repeated gene family and its epidemiologic applications. Proc. Natl. Acad. Sci. USA 85:1452-1456.
32. Schmid, J., M. Rotman, B. Reed, C. L. Pierson, and D. R. Soll. 1993. Genetic similarity of Candida albicans strains from vaginitis patients and their partners. J. Clin. Microbiol. 31:39-46.
33. Schönian, G., O. Meusel, H.-J. Tietz, W. Meyer, Y. Gräser, I. Tausch, W. Presber, and T. G. Mitchell. 1993. Identification of clinical strains of Candida albicans by DNA fingerprinting with the polymerase chain reaction. Mycoses 36:171-179.
34. Schröppel, K., M. Rotman, R. Galask, K. Mac, and D. R. Soll. 1994. Evolution and replacement of Candida albicans strains during recurrent vaginitis demonstrated by DNA fingerprinting. J. Clin. Microbiol. 32:2646-2654.
35. Smego, R. A., Jr., J. R. Perfect, and D. T. Durack. 1984. Combined therapy with amphotericin B and 5-fluorocytosine for Candida meningitis. Rev. Infect. Dis. 6:791-801.
36. Soll, D. R., R. Galask, J. Schmid, C. Hanna, K. Mac, and B. Morrow. 1991. Genetic dissimilarity of commensal strains of Candida spp. carried in different anatomical locations of the same healthy women. J. Clin. Microbiol. 29:1702-1710.
37. Soll, D. R., M. Staebell, C. Langtimm, M. Pfaller, J. Hicks, and T. V. Gopala Rao. 1988. Multiple Candida strains in the course of a single systemic infection. J. Clin. Microbiol. 26:1448-1459.
38. Vassart, G., M, Georges, R. Monsieur, H. Brocas, A. S. Lequarre, and D. Christophe. 1987. A sequence in M13 phage detects hypervariable minisatellites in human and animal DNA. Science 235:683-684.